BACKGROUND: Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant cancer susceptibility genes. Underlying genetic heterogeneity, as well as the high sporadic background of the disease, has resulted in many signals that are often not reproducible between research studies. METHODS: We conducted a SNP-based genome wide linkage scan on 131 Caucasian prostate cancer families participating in the University of Michigan Prostate Cancer Genetics Project (PCGP). RESULTS: The strongest evidence for linkage was detected at 16q23 (LOD = 2.70 at rs1079635). Prostate cancer linkage to the same region of 16q23 has been observed by others and the region contains several strong candidate genes including the known prostate cancer tumor suppressor genes ATBF1 and WWOX. This linkage signal was not detected in our prior linkage study on 175 PCGP families, illustrating the genetic heterogeneity underlying prostate cancer susceptibility. CONCLUSIONS: Further linkage studies in combination with tumor analyses from linked families are in progress to identify the putative hereditary prostate cancer gene at 16q23. 2008 Wiley-Liss, Inc.
BACKGROUND:Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant cancer susceptibility genes. Underlying genetic heterogeneity, as well as the high sporadic background of the disease, has resulted in many signals that are often not reproducible between research studies. METHODS: We conducted a SNP-based genome wide linkage scan on 131 Caucasian prostate cancer families participating in the University of Michigan Prostate Cancer Genetics Project (PCGP). RESULTS: The strongest evidence for linkage was detected at 16q23 (LOD = 2.70 at rs1079635). Prostate cancer linkage to the same region of 16q23 has been observed by others and the region contains several strong candidate genes including the known prostate cancer tumor suppressor genes ATBF1 and WWOX. This linkage signal was not detected in our prior linkage study on 175 PCGP families, illustrating the genetic heterogeneity underlying prostate cancer susceptibility. CONCLUSIONS: Further linkage studies in combination with tumor analyses from linked families are in progress to identify the putative hereditary prostate cancer gene at 16q23. 2008 Wiley-Liss, Inc.
Authors: B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona Journal: Am J Hum Genet Date: 2000-03 Impact factor: 11.025
Authors: B K Suarez; J Lin; J S Witte; D V Conti; M I Resnick; E A Klein; J K Burmester; D A Vaske; T K Banerjee; W J Catalona Journal: Prostate Date: 2000-10-01 Impact factor: 4.104
Authors: Ethan M Lange; Elizabeth M Gillanders; Cralen C Davis; W Mark Brown; Joel K Campbell; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Veda Giri; Jennifer Beebe Dimmer; James E Montie; Jeffrey M Trent; Kathleen A Cooney Journal: Prostate Date: 2003-12-01 Impact factor: 4.104
Authors: Jianfeng Xu; Elizabeth M Gillanders; Sarah D Isaacs; Bao-Li Chang; Kathy E Wiley; S Lilly Zheng; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; William B Isaacs Journal: Prostate Date: 2003-12-01 Impact factor: 4.104
Authors: J E Vivienne Watson; Norman A Doggett; Donna G Albertson; Armann Andaya; Arul Chinnaiyan; Herman van Dekken; David Ginzinger; Christopher Haqq; Karen James; Sherwin Kamkar; David Kowbel; Daniel Pinkel; Lars Schmitt; Jeffry P Simko; Stanislav Volik; Vivian K Weinberg; Pamela L Paris; Colin Collins Journal: Oncogene Date: 2004-04-22 Impact factor: 9.867
Authors: John S Witte; Brian K Suarez; Bonnie Thiel; Jennifer Lin; Adong Yu; Tarit K Banerjee; James K Burmester; Graham Casey; William J Catalona Journal: Prostate Date: 2003-12-01 Impact factor: 4.104
Authors: Federico Innocenti; Kouros Owzar; Nancy L Cox; Patrick Evans; Michiaki Kubo; Hitoshi Zembutsu; Chen Jiang; Donna Hollis; Taisei Mushiroda; Liang Li; Paula Friedman; Liewei Wang; Dylan Glubb; Herbert Hurwitz; Kathleen M Giacomini; Howard L McLeod; Richard M Goldberg; Richard L Schilsky; Hedy L Kindler; Yusuke Nakamura; Mark J Ratain Journal: Clin Cancer Res Date: 2011-12-05 Impact factor: 12.531
Authors: Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker Journal: Int J Cancer Date: 2011-04-20 Impact factor: 7.396
Authors: Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney Journal: N Engl J Med Date: 2012-01-12 Impact factor: 91.245
Authors: Niki Tomas Loges; Heike Olbrich; Anita Becker-Heck; Karsten Häffner; Angelina Heer; Christina Reinhard; Miriam Schmidts; Andreas Kispert; Maimoona A Zariwala; Margaret W Leigh; Michael R Knowles; Hanswalter Zentgraf; Horst Seithe; Gudrun Nürnberg; Peter Nürnberg; Richard Reinhardt; Heymut Omran Journal: Am J Hum Genet Date: 2009-12 Impact factor: 11.025
Authors: Ethan M Lange; Anna M Johnson; Yunfei Wang; Kimberly A Zuhlke; Yurong Lu; Jessica V Ribado; Gregory R Keele; Jin Li; Qing Duan; Ge Li; Zhengrong Gao; Yun Li; Jianfeng Xu; William B Isaacs; Siqun Zheng; Kathleen A Cooney Journal: PLoS One Date: 2014-04-16 Impact factor: 3.240